San Jose, CA, United States of America

Matthew B Lee

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Talis Biomedical Corporation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew B Lee. Retrieved from https://idiyas.com/inventor/matthew-b-lee-pnfci75j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Matthew B. Lee

Introduction

Matthew B. Lee is an accomplished inventor based in San Jose, California. He has made significant contributions to the field of molecular biology, particularly in the detection of infectious diseases. His work has led to the development of innovative methods that enhance diagnostic capabilities.

Latest Patents

Matthew B. Lee holds a patent for "Polynucleotides for the amplification and detection of Chlamydia trachomatis." This invention provides methods and compositions for detecting the presence or absence of Chlamydia trachomatis in a test sample. The detection is achieved through nucleic acid-based testing methods that utilize primers, probes, and molecular beacons that bind to the 16S or 23S ribosomal genes or gene transcripts.

Career Highlights

Matthew is currently employed at Talis Biomedical Corporation, where he continues to advance his research and development efforts. His work at Talis Biomedical Corporation focuses on creating innovative solutions for diagnostic testing, contributing to the improvement of healthcare outcomes.

Collaborations

Matthew has collaborated with notable colleagues, including Hedia Maamar and Hédia Maamar, to further enhance the impact of his inventions. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Matthew B. Lee's contributions to the field of molecular diagnostics exemplify the importance of innovation in healthcare. His patented methods for detecting Chlamydia trachomatis represent a significant advancement in diagnostic technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…